Found: 6
Select item for more details and to access through your institution.
Linagliptin and telmisartan induced effects on renal and urinary exosomal miRNA expression in rats with 5/6 nephrectomy.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60336-4
- By:
- Publication type:
- Article
Comparison of pioglitazone and gliclazide in sustaining glycemic control over 2 years in patients with type 2 diabetes.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Comparison of Pioglitazone and Gliclazide in Sustaining Glycemic Control Over 2 Years in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2005, v. 28, n. 3, p. 544
- By:
- Publication type:
- Article
The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 3, p. 423, doi. 10.1007/s00228-012-1382-7
- By:
- Publication type:
- Article
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0150154
- By:
- Publication type:
- Article
Evaluation of the Impact of UGT Polymorphism on the Pharmacokinetics and Pharmacodynamics of the Novel PPAR Agonist Sipoglitazar.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 3, p. 256, doi. 10.1177/0091270012447121
- By:
- Publication type:
- Article